Page last updated: 2024-11-02

oxophenylarsine and Bone Loss, Osteoclastic

oxophenylarsine has been researched along with Bone Loss, Osteoclastic in 1 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, A1
Rutledge, SJ1
Endo, N1
Opas, EE1
Tanaka, H1
Wesolowski, G1
Leu, CT1
Huang, Z1
Ramachandaran, C1
Rodan, SB1
Rodan, GA1

Other Studies

1 other study available for oxophenylarsine and Bone Loss, Osteoclastic

ArticleYear
Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-02, Volume: 93, Issue:7

    Topics: Alendronate; Amino Acid Sequence; Animals; Arsenicals; Bone Marrow Cells; Bone Resorption; Cloning,

1996